Skip to main content

. 1981 May 30;282(6278):1756–1757. doi: 10.1136/bmj.282.6278.1756-a

Dangers of amiodarone and anticoagulant treatment.

A Rees, J J Dalal, P G Reid, A H Henderson, M J Lewis

PMCID: PMC1505759 PMID: 6786610

1756

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

Charlier R., Deltour G., Baudine A., Chaillet F. Pharmacology of amiodarone, and anti-anginal drug with a new biological profile. Arzneimittelforschung. 1968 Nov;18(11):1408–1417. [PubMed] [Google Scholar]
Rowland E., Krikler D. M. Electrophysiological assessment of amiodarone in treatment of resistant supraventricular arrhythmias. Br Heart J. 1980 Jul;44(1):82–90. doi: 10.1136/hrt.44.1.82. [DOI] [PMC free article] [PubMed] [Google Scholar]
Singh B. N., Vaughan Williams E. M. The effect of amiodarone, a new anti-anginal drug, on cardiac muscle. Br J Pharmacol. 1970 Aug;39(4):657–667. doi: 10.1111/j.1476-5381.1970.tb09891.x. [DOI] [PMC free article] [PubMed] [Google Scholar]

ACTIONS

RESOURCES